Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71205-621 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71205-621-60 - pregabalin 75mg 90s

71205-621-60 - pregabalin 75mg 90s

This is the label of Pregabalin 75mg capsules packaged by Proficient Rx LP with lot number, expiration date, and NDC code mentioned. The capsules have white/orange color with 'A009' and 'PREG 75' imprinted on the cap and body respectively. The manufacturer is Alkem Laboratories Ltd., Mumbai - 400 013, INDIA. It is an RX-only medicine and should be stored at 25°C away from children. There is also a mention of the medication guide to be given to each patient.*

pregabalin-equation - pregabalin equation

pregabalin-equation - pregabalin equation

This text appears to be a formulaic expression commonly used in medical laboratories to calculate the estimated creatinine clearance (CLCr) of a patient, which is a measure of their kidney function. The formula requires the patient's age and weight, as well as their serum creatinine level (measured in mg/dL). The value of CLCr is then determined based on these inputs, alongside a correction factor (0.85 for female patients). However, without further context or instructions for how to use the formula, this text is not particularly useful on its own.*

pregabalin-Figure-6 - pregabalin figure 6

pregabalin-Figure-6 - pregabalin figure 6

This appears to be a table of results from two different studies labeled as "Study E1" and "Study E3". The table shows the percentage results of different treatment dosages (ranging from 50mg/day to 600mg/day) compared to a placebo, for an unknown subject. The last row shows that the results were statistically significant compared to the placebo. There is not enough information to determine what the treatment was for or any other details about the studies.*

pregabalin-Figure-7 - pregabalin figure 7

pregabalin-Figure-7 - pregabalin figure 7

Study DPN 1 - pregabalin image 1

Study DPN 1 - pregabalin image 1

Study SCI 1 - pregabalin image 10

Study SCI 1 - pregabalin image 10

Pain Intensity-study SCI 2 - pregabalin image 11

Pain Intensity-study SCI 2 - pregabalin image 11

Study DPN 2 - pregabalin image 2

Study DPN 2 - pregabalin image 2

Study PHN 1 - pregabalin image 3

Study PHN 1 - pregabalin image 3

Study PHN 2 - pregabalin image 4

Study PHN 2 - pregabalin image 4

Study PHN 3 - pregabalin image 5

Study PHN 3 - pregabalin image 5

Fibromyalgia Study F1 - pregabalin image 8

Fibromyalgia Study F1 - pregabalin image 8

This appears to be a chart showing the percentage of patients who experienced improvement in pain from baseline with different doses of pregabalin. The chart displays percentages ranging from 0% to 100%, with the highest improvement seen in patients taking a daily dose of 600mg (labeled as "Pregabalin 450mg daiy dose" and "Pregabaiin 300mg dai dose" are other dosages), while the lowest improvement was seen in patients taking a daily dose of 100mg ("Fiacsto").*

Fibromyalgia Study F2 - pregabalin image 9

Fibromyalgia Study F2 - pregabalin image 9

Pregabalin structure - pregabalin srtuc 1

Pregabalin structure - pregabalin srtuc 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.